Has Christopher Chuinard, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,442,179 in general payments to Christopher Chuinard, MD across 284 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Christopher Chuinard, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Christopher Chuinard, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Christopher Chuinard, MD

Orthopaedic Surgery · Traverse City, MINPI 1205926268

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $1,103,583 of the $1,442,179 with a category attached, or 76.5%. 19 manufacturers reported payments, led by Stryker at 56.4% of the total. 2025 is the largest year on record at $422,497, 2.9 times the $147,394 reported in 2019. Among orthopaedic surgery clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,442,179in general payments, 2019–2025

Across 284 payments — averaging $5078.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$813K
Shoulder Innovations, Inc.$573K
Encore Medical, LP$49K
Medical Device Business Services, Inc.$2K
Depuy Synthes Products, Inc.$2K
Azurmeds, Inc.$718
plus $2K from 13 others

$12,203in research payments, 2019–2025

Across 7 payments — averaging $1743.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Stryker$12K

What the payments were for

Royalty or licence$1,103,58377%
Consulting fees$269,15019%
Speaking & faculty fees$16,5001%
Travel & lodging$41,9913%
Food & beverage$10,1691%
Gifts$7250%
Entertainment$610%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker(2 entities)	84	$813,381
Shoulder Innovations, Inc.	117	$573,472
Encore Medical, LP	44	$48,883
Medical Device Business Services, Inc.	2	$2,395
Depuy Synthes Products, Inc.	2	$1,545
Azurmeds, Inc.	3	$718
Catalyst Orthoscience	4	$452
Exactech, Inc.	3	$372
Medacta USA, Inc.	3	$294
Ossur Americas, Inc.	2	$112
Sunovion Pharmaceuticals Inc.	10	$100
Johnson & Johnson	1	$99
Surgalign Spine Technologies, Inc.	1	$76
Integrity Orthopaedics, Inc.	1	$75
Linvatec Corporation	2	$70
Medwest Associates	1	$67
Embody, Inc.	2	$27
Arthrex	1	$20
Zimvie Inc.	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

InSet System$530,645
AEQUALIS PERFORM$522,664
AEQUALIS$197,560
PHALINX$45,947
DJO Surgical Discovery Elbow System$27,828
DJO SURGICAL$27,454
R&D UPPER EXT$18,000
Shoulder Innovations Humeral Short Stem System$16,896
DJO Surgical AltiVate Reverse$11,123
DJO Surgical AltiVate Anatomic System$10,813
BLUEPRINT PSI SYSTEM$9,500
PROstep$6,969
ORTHOLOC$3,135
NEW PRODUCT DEVELOPMENT$2,877
HEALIX KNOTLESS PEEK$2,318
DYNACORD$2,318
INTRAFIX$2,318
NA$2,318
TORNIER PERFORM REVERSED AUGMENTED GLENOID$1,125
BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION$1,000

How this compares

$1,442,179 in reported general payments places this provider in the 95th percentile of 829 orthopaedic surgery providers in Michigan.

See all orthopaedic surgery providers in Michigan →

Medicare billing

Part B allowed, 2024

$168,432

Medicare patients

224

Services billed

1,267

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Meloxicam	464	$1,390
Calcitonin-SalmonCalcitonin,salmon,synthetic	11	$564
Nabumetone	20	$363
Tizanidine Hcl	52	$230
Gabapentin	37	$219
Ondansetron Hcl	39	$208
Doxycycline Hyclate	29	$200
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	17	$83
Mupirocin	15	$80
Amoxicillin	13	$25

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Traverse City

Asheesh BediAnn Arbor$9.4M
Jerome WiaterBeverly Hills$3.9M
Mark PintoChelsea$3.2M
Kyle AndersonBingham Farms$3.1M
Stephen BartolDetroit$2.6M
Jad KhalilSouthfield$1.9M
Jeffrey FischgrundSouthfield$1.8M
John BlahaAnn Arbor$1.5M
David MarkelSouthfield$1.5M
Shariff BishaiTroy$1.2M

See the full list for Michigan →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →